SCHEMBL24310513

SCHEMBL24310513

CCc1c(Oc2cccc(N3CCN(C)CC3)c2Cl)nc(NSc2cnn(C)c2)nc1-c1ccccc1OCC(C)C

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ DRD4 P21917 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR2C P28335 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ MELK Q14680 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ BRD9 Q9H8M2 1/20 0.32
▸ PAK1 Q13153 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MAP3K7 O43318 1/20 0.30
▸ MAP2K1 Q02750 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310049 0.93 PAK1 (0.36) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL24309430 0.92 PAK1 (0.32) MEN1POLBKMT2AHRH4HTR1A
SCHEMBL24309536 0.92 BRPF1 (0.34) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL24309479 0.90 HTR1A (0.33) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL24310089 0.89 DRD2 (0.35) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL24310065 0.88 DRD2 (0.37) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL24310772 0.86 HTR1A (0.33) HTR1ADRD2DRD4HTR2AHTR2C
SCHEMBL29566861 0.85 HTR1A (0.36) MEN1POLBKMT2AHRH4HTR1A
SCHEMBL26811393 0.85 HTR1A (0.36) MEN1POLBKMT2AHRH4HTR1A
SCHEMBL24309527 0.84 DRD2 (0.39) HTR1ADRD2DRD4HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback